DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,915,324 | -9.1% | 325,371 | +14.1% | 0.00% | 0.0% |
| Q2 2023 | $3,207,611 | +22.3% | 285,121 | +25.3% | 0.00% | 0.0% |
| Q1 2023 | $2,621,768 | -0.8% | 227,584 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $2,644,166 | -6.4% | 228,142 | +2.6% | 0.00% | 0.0% |
| Q3 2022 | $2,825,000 | +129.5% | 222,434 | +24.2% | 0.00% | – |
| Q2 2022 | $1,231,000 | -33.7% | 179,153 | -6.9% | 0.00% | -100.0% |
| Q1 2022 | $1,856,000 | -17.2% | 192,477 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $2,242,000 | -25.1% | 188,559 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $2,992,000 | -6.2% | 184,183 | +21.5% | 0.00% | 0.0% |
| Q2 2021 | $3,191,000 | +67.7% | 151,626 | +23.8% | 0.00% | 0.0% |
| Q1 2021 | $1,903,000 | +10.1% | 122,492 | +48.9% | 0.00% | 0.0% |
| Q4 2020 | $1,728,000 | – | 82,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |